Unsuccessful Xpert® MTB/RIF results: the Nigerian experience
- 21 March 2018
- journal article
- research article
- Published by International Union Against Tuberculosis and Lung Disease in Public Health Action
- Vol. 8 (1), 2-6
- https://doi.org/10.5588/pha.17.0080
Abstract
Setting: Nigeria, a high tuberculosis (TB) burden country. Objective: To study the rate, distribution and causes of unsuccessful Xpert® MTB/RIF test outcomes, with the aim of identifying key areas that need to be strengthened for optimal performance of the assay. Design: This was a retrospective analysis of data uploaded between January and December 2015 from Xpert facilities to the central server using GXAlert. Result: Of 52 219 test results uploaded from 176 Xpert machines, 22.5% were positive for Mycobacterium tuberculosis, 10.8% of which were rifampicin-resistant; 4.7% of the total number of results were invalid, 4.2% had error results and 2.1% no result outcomes. Technical errors were most frequent (69%); these were non-seasonal and occurred in all geopolitical regions and at all health facility levels. Temperature-related errors were more prevalent in the North-West Region, with peaks in April to June. Peak periods for temperature and machine malfunction errors coincided with the periods of low utilisation of the assay. Conclusion: The key challenge affecting performance was poor adherence to standard operating procedures. Periodic refresher training courses, regular supervision, preventive maintenance of Xpert machines and proper storage of cartridges are strategies that could improve Xpert performance.This publication has 16 references indexed in Scilit:
- Molecular analysis of rpoB gene mutations in rifampicin resistant Mycobacterium tuberculosis isolates by multiple allele specific polymerase chain reaction in Puducherry, South IndiaJournal of Infection and Public Health, 2015
- Evaluating the Diagnostic Accuracy of Xpert MTB/RIF Assay in Pulmonary TuberculosisPLOS ONE, 2015
- Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in IndiaPLOS ONE, 2015
- Impact on Patients’ Treatment Outcomes of XpertMTB/RIF Implementation for the Diagnosis of Tuberculosis: Follow-Up of a Stepped-Wedge Randomized Clinical TrialPLOS ONE, 2015
- Catching the Missing Million: Experiences in Enhancing TB & DR-TB Detection by Providing Upfront Xpert MTB/RIF Testing for People Living with HIV in IndiaPLOS ONE, 2015
- Impact of Replacing Smear Microscopy with Xpert MTB/RIF for Diagnosing Tuberculosis in Brazil: A Stepped-Wedge Cluster-Randomized TrialPLoS Medicine, 2014
- An evaluation of the Xpert MTB/RIF assay and detection of false-positive rifampicin resistance in Mycobacterium tuberculosisDiagnostic Microbiology and Infectious Disease, 2012
- Xpert®MTB/RIF for point-of-care diagnosis of TB in high-HIV burden, resource-limited countries: hype or hope?Expert Review of Molecular Diagnostics, 2010
- Retrospective research: What are the ethical and legal requirements?Swiss Medical Weekly, 2010
- Meta-Analysis of BACTEC MGIT 960 and BACTEC 460 TB, with or without Solid Media, for Detection of MycobacteriaJournal of Clinical Microbiology, 2004